Thomas Saylor

Thomas Saylor is an accomplished executive with extensive experience in the biotechnology and pharmaceutical industries, currently serving as Chief Executive Officer of NeuroAcoustics, Inc., where the focus is on developing devices for enhancing non-REM sleep to address neurological conditions. Saylor holds advisory positions with the Georgia Research Alliance and VIC Technology Venture Development™ and has a history of founding and leading companies such as Guide Therapeutics, which aims to innovate gene therapy delivery. Past roles include CEO positions at Arecor Limited, Insense Limited, Sirus Limited, Lotus Healthcare Corporation, and Cell Systems Limited, managing diverse areas such as advanced pharmaceuticals and medical devices. Saylor's academic background includes an MBA from Harvard University and a BS in Molecular Biology from Georgia Institute of Technology.